Related Experiment Video
Updated: Jul 4, 2026

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity
Published on: February 9, 2024
Integrative genomics analysis of chromosome 5p gain in cervical cancer reveals target over-expressed genes, including
Luigi Scotto1, Gopeshwar Narayan, Subhadra V Nandula
1Department of Pathology, Columbia University Medical Center, New York, New York, USA. ls339@columbia.edu
Background:
Copy number gains and amplifications are characteristic feature of cervical cancer (CC) genomes for which the underlying mechanisms are unclear. These changes may possess oncogenic properties by deregulating tumor-related genes. Gain of short arm of chromosome 5 (5p) is the most frequent karyotypic change in CC.
Methods:
To examine the role of 5p gain, we performed a combination of single nucleotide polymorphism (SNP) array, fluorescence in situ hybridization (FISH), and gene expression analyses on invasive cancer and in various stages of CC progression.
Results:
The SNP and FISH analyses revealed copy number increase (CNI) of 5p in 63% of invasive CC, which arises at later stages of precancerous lesions in CC development. We integrated chromosome 5 genomic copy number and gene expression data to identify key target over expressed genes as a consequence of 5p gain. One of the candidates identified was Drosha (RNASEN), a gene that is required in the first step of microRNA (miRNA) processing in the nucleus. Other 5p genes identified as targets of CNI play a role in DNA repair and cell cycle regulation (BASP1, TARS, PAIP1, BRD9, RAD1, SKP2, and POLS), signal transduction (OSMR), and mitochondrial oxidative phosphorylation (NNT, SDHA, and NDUFS6), suggesting that disruption of pathways involving these genes may contribute to CC progression.
Conclusion:
Taken together, we demonstrate the power of integrating genomics data with expression data in deciphering tumor-related targets of CNI. Identification of 5p gene targets in CC denotes an important step towards biomarker development and forms a framework for testing as molecular therapeutic targets.
Insights
Copy number gains on chromosome 5p are frequent in cervical cancer (CC). This study identified key genes affected by 5p gain, offering potential for new biomarkers and therapies for CC.
Area of Science:
- Genomics
- Cancer Biology
- Molecular Oncology
Background:
- Copy number gains and amplifications are common in cervical cancer (CC) genomes.
- The mechanisms driving these genomic alterations and their oncogenic role are not fully understood.
- Gain of the short arm of chromosome 5 (5p) is the most frequent karyotypic alteration observed in CC.
Purpose of the Study:
- To investigate the role of 5p gain in cervical cancer development and progression.
- To identify specific genes on chromosome 5p that are overexpressed due to copy number increase.
- To understand the functional implications of these 5p gene targets in CC pathogenesis.
Main Methods:
- Utilized single nucleotide polymorphism (SNP) array and fluorescence in situ hybridization (FISH) to detect copy number changes on 5p.
- Performed gene expression analysis on invasive CC and precancerous lesions.
- Integrated genomic copy number and gene expression data to identify key target genes.
Main Results:
- Copy number increase (CNI) of 5p was observed in 63% of invasive CC cases, emerging at later stages of lesion progression.
- Integrated analysis identified Drosha (RNASEN) as a key target gene involved in microRNA processing.
- Other identified 5p targets include genes involved in DNA repair, cell cycle regulation, signal transduction, and mitochondrial function, suggesting pathway disruption in CC.
Conclusions:
- Integrating genomics and expression data is powerful for identifying tumor-related targets of copy number changes.
- The identified 5p gene targets in CC are crucial for understanding tumor development.
- These findings provide a foundation for developing novel biomarkers and molecular therapeutic strategies for cervical cancer.
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Induced Pluripotent Stem Cells
Somatic cells are...
